Stay updated on Cemdisiran in IgA Nephropathy: Adult Clinical Trial
Sign up to get notified when there's something new on the Cemdisiran in IgA Nephropathy: Adult Clinical Trial page.
Latest updates to the Cemdisiran in IgA Nephropathy: Adult Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference4%
- Check18 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check54 days agoChange DetectedThe study's early termination due to significant proteinuria reduction from cemdisiran has been updated, with the latest revision indicating no safety concerns from the sponsor.SummaryDifference2%
- Check75 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
Stay in the know with updates to Cemdisiran in IgA Nephropathy: Adult Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemdisiran in IgA Nephropathy: Adult Clinical Trial page.